You must pre register to attend this workshop
Location: Griffith University, Ian O'Connor Building (Griffith Health Centre) G40, Level 4, Room 4.111
Workshop facilitators: Emeritus Prof Peter Howe, The University of Newcastle, Dr Samaneh Fard, Nu-Mega Ingredients & Prof Barbara Meyer, University of Wollongong
Description: This workshop will explore the latest evidence and strategies for improving omega-3 status across the lifespan, from preterm infants and toddlers to adults. Expert speakers will present research on fatty acid profile, DHA bioavailability, Omega-3 Index, supplementation approaches, and clinical and public health applications. Topics include results from trials of high-DHA sachets, microencapsulated tuna oil toddler formula, and lipid emulsions, as well as strategies to achieve an optimal Omega-3 Index of 8%. The workshop is highly interactive. Attendees will participate in an Omega-3 Index testing opportunity, with samples analysed by OmegaQuant (USA) and results provided after the conference. This hands-on component will familiarise participants with biomarker testing and interpretation. Small-group breakout discussions will allow participants to interpret mock or real Omega-3 Index results, design supplementation or fortification strategies, and consider practical challenges in research and clinical practice. The session concludes with a plenary Q&A panel, ensuring participants leave with practical skills and strategies relevant to nutrition practice and policy.
Expected outcomes: Participants will gain an up-to-date understanding of omega-3 fatty acids and the Omega-3 Index, including their role as biomarkers of health. They will learn how different delivery systems (sachets, microencapsulated formulas, lipid emulsions) influence DHA bioavailability and status. Through hands-on Omega-3 Index testing and interactive discussions, participants will develop practical skills in interpreting results and designing supplementation or fortification strategies. Outcomes include improved confidence in applying research evidence to clinical, community, and policy settings.
NSA 2025